Marlène Thomas

HER2 screening data from ToGA: targeting HER2 in gastric and gastroesophageal junction cancer

Eric Van Cutsem, Yung‐Jue Bang, Feng-yi Feng et al. · Gastric Cancer · 2014 · 609 citations · Full text

Medicine, Molecular Medicine, Oncology +17

Research-Based PAM50 Subtype Predictor Identifies Higher Responses and Improved Survival Outcomes in HER2-Positive Breast Cancer in the NOAH Study

Aleix Prat, Giampaolo Bianchini, Marlène Thomas et al. · Clinical Cancer Research · 2014 · 236 citations

Medicine, Molecular Medicine, Oncology +17

The Impact of Differentiated Instruction in a Teacher Education Setting: Successes and Challenges

Stephen Joseph, Marlène Thomas, Gerard Simonette et al. · International Journal of Higher Education · 2013 · 117 citations · Full text

Education, Teacher Education, Teaching +13

First-in-Human Phase I Study of Lumretuzumab, a Glycoengineered Humanized Anti-HER3 Monoclonal Antibody, in Patients with Metastatic or Advanced HER3-Positive Solid Tumors

Didier Meulendijks, Wolfgang Jacob, Maria Martinez‐García et al. · Clinical Cancer Research · 2015 · 75 citations · Full text

Medicine, Oncology, Pharmacology +17

Molecularly guided therapy versus chemotherapy after disease control in unfavourable cancer of unknown primary (CUPISCO): an open-label, randomised, phase 2 study

Alwin Krämer, Tilmann Bochtler, Chantal Pauli et al. · The Lancet · 2024 · 75 citations · Full text

Medicine, Clinical Sciences, Oncology +8